Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2026-01-03 @ 11:05 PM
Study NCT ID:
NCT03226756
Status:
COMPLETED
Last Update Posted:
2023-01-18
First Post:
2017-07-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nivolumab in Recurrent and/or Metastatic SCCHN
Sponsor:
UNICANCER
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
UC-0130/1703
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |